<p>There are 189 fully characterized patient cases that make up the pilot phase (Phase I) of the TARGET ALL dataset, each with gene expression, tumor and paired normal copy number  analyses, and at least one type of sequencing (Sanger and/or next-generation) data available. There are 230 cases with partial molecular</p>

TARGET: Acute Lymphoblastic Leukemia (ALL) Pilot Phase 1

Precursor Cell Lymphoblastic Leukemia-Lymphoma study with RNA-Seq, WGS data on CRDC (289 participants)